drugset / Trial / NCT06364111

Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation

NCT06364111

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-center trial that enrolls 20 18 to 85-year-old patients with moderate to severe FC to study the efficacy of Vibrabot capsule (dosage: 5 capsules/week) and polyethylene glycol, as well as the mechanism of action of the Vibrabot capsule.

Timeline

Start
2024-01-08
Primary completion
2025-06-14
Completion
2025-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified 10 g

Indications